TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years
OPINION

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

  • By Brian Sozzi
  • Mar 14, 2018 6:23 PM EDT
PRESS RELEASES

ChemoCentryx Appoints Tausif ('Tosh') Butt As Executive Vice President And Chief Operating Officer

  • By GlobeNewswire
  • Feb 24, 2021 8:30 AM EST
PRESS RELEASES

ChemoCentryx To Hold Fourth Quarter And Full Year 2020 Financial Results Conference Call on Monday, March 1, 2021

  • By GlobeNewswire
  • Feb 23, 2021 8:30 AM EST
PRESS RELEASES

ChemoCentryx Announces Publication In The New England Journal Of Medicine Of Results Of The Pivotal Phase III ADVOCATE Trial Of Avacopan For The Treatment Of ANCA-Associated Vasculitis

  • By GlobeNewswire
  • Feb 17, 2021 5:00 PM EST
PRESS RELEASES

ChemoCentryx To Participate In Two Upcoming Investor Conferences

  • By GlobeNewswire
  • Jan 6, 2021 8:30 AM EST
PRESS RELEASES

ChemoCentryx To Present At Two Upcoming Investor Conferences

  • By GlobeNewswire
  • Nov 19, 2020 8:30 AM EST
PRESS RELEASES

ChemoCentryx Announces Plenary Session At ACR Convergence 2020 To Highlight Findings Of ADVOCATE Phase III Trial In ANCA-Associated Vasculitis

  • By GlobeNewswire
  • Nov 6, 2020 8:30 AM EST
PRESS RELEASES

ChemoCentryx To Hold Third Quarter 2020 Financial Results Conference Call On Monday, November 9, 2020

  • By GlobeNewswire
  • Nov 2, 2020 8:30 AM EST
PRESS RELEASES

ChemoCentryx Announces FDA Acceptance Of The Avacopan New Drug Application (NDA) For The Treatment Of ANCA-Associated Vasculitis

  • By GlobeNewswire
  • Sep 17, 2020 8:30 AM EDT
PRESS RELEASES

ChemoCentryx To Present At The H.C. Wainwright 22nd Annual Global Investment Conference

  • By GlobeNewswire
  • Sep 8, 2020 8:30 AM EDT
PRESS RELEASES

ChemoCentryx To Present At Two Upcoming Investor Conferences

  • By GlobeNewswire
  • Aug 4, 2020 8:30 AM EDT
PRESS RELEASES

ChemoCentryx To Hold Second Quarter 2020 Financial Results Conference Call On Monday, August 10, 2020

  • By GlobeNewswire
  • Aug 3, 2020 8:30 AM EDT
PRESS RELEASES

ChemoCentryx Submits New Drug Application To The U.S. FDA For Avacopan In ANCA-Associated Vasculitis

  • By GlobeNewswire
  • Jul 9, 2020 8:30 AM EDT
PRESS RELEASES

ChemoCentryx Identifies Novel Orally Administered Immune Checkpoint Inhibitor CCX559 For Next Generation Cancer Treatment

  • By GlobeNewswire
  • Jun 24, 2020 8:30 AM EDT
PRESS RELEASES

ChemoCentryx Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

  • By GlobeNewswire
  • Jun 15, 2020 4:05 PM EDT
PRESS RELEASES

ChemoCentryx Prices Public Offering Of Common Stock

  • By GlobeNewswire
  • Jun 10, 2020 9:33 PM EDT
PRESS RELEASES

ChemoCentryx Announces Proposed Public Offering Of Common Stock

  • By GlobeNewswire
  • Jun 10, 2020 4:08 PM EDT
PRESS RELEASES

ChemoCentryx Phase III ADVOCATE Trial Of Avacopan In ANCA-Associated Vasculitis Highlighted In Oral Plenary Presentations At EULAR And ERA-EDTA Congresses

  • By GlobeNewswire
  • Jun 3, 2020 7:30 AM EDT
PRESS RELEASES

ChemoCentryx To Hold First Quarter 2020 Financial Results Conference Call on Monday, May 11, 2020

  • By GlobeNewswire
  • May 4, 2020 8:30 AM EDT
PRESS RELEASES

ChemoCentryx To Hold Fourth Quarter And Full Year 2019 Financial Results Conference Call on Tuesday, March 10, 2020

  • By GlobeNewswire
  • Mar 3, 2020 8:30 AM EST
PRESS RELEASES

ChemoCentryx To Present At The 9th Annual SVB Leerink Global Healthcare Conference

  • By GlobeNewswire
  • Feb 19, 2020 8:30 AM EST
Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years
OPINION

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

  • By Brian Sozzi
  • Mar 14, 2018 6:23 PM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix

  • By Armie Margaret Lee
  • Mar 10, 2017 9:29 AM EST
Biotech Premarket Movers: PTC, Teligent, Minerva
OPINION

These 5 stocks are poised for big breakouts

  • By Roberto Pedone
  • Apr 1, 2016 8:43 AM EDT
5 Bargain Bin Stocks to Buy in March
INVESTING

3 Stocks Under $10 Moving Higher

  • By Roberto Pedone
  • May 2, 2014 8:08 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.